Global Electrophysiology Market Report (2022 to 2028) - Featuring Abbott Laboratories, Boston Scientific and General Electric Among Others
22 juin 2022 06h28 HE
|
Research and Markets
Dublin, June 22, 2022 (GLOBE NEWSWIRE) -- The "Global Electrophysiology Market Size, Share & Industry Trends Analysis Report By Type, By End User, By Indication Type (Atrial Fibrillation, Atrial...
By 2028, Demand for Electrophysiology Market Size $14.84 Billion at 10.2% CAGR Lead by Atrial Fibrillation (11% CAGR in 2028) Global Analysis by The Insight Partners
20 juin 2022 07h01 HE
|
The Insight Partners
New York, June 20, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Electrophysiology Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product...
Impulse Dynamics Announces First International Implants of the Optimizer Smart Mini System in Italy
14 juin 2022 04h00 HE
|
Impulse Dynamics
MARLTON, N.J., June 14, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics, a commercial-stage medical device company focused on delivering our CCM therapy to people with heart failure, announced that the...
BioSig Advances its PURE™ System Commercial Launch to Medical Centers Nationwide
26 mai 2022 09h08 HE
|
BioSig Technologies, Inc.
Westport, CT, May 26, 2022 (GLOBE NEWSWIRE) -- Commercial pipeline to include 30 advanced leads at Medical Centers of Excellence Company’s development and operational infrastructure...
BioSig’s PURE EP™ System to be Featured During EPLive 2022
25 mai 2022 09h47 HE
|
BioSig Technologies, Inc.
Westport, CT, May 25, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company advancing electrophysiology workflow by delivering...
BioSig Technologies, Inc. Issues Shareholder Letter with Corporate Update on Recent Achievements
11 mai 2022 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, May 11, 2022 (GLOBE NEWSWIRE) -- To date, Company's FDA 510(k) cleared PURE EP(TM) system has completed over 2,200 patient cases with 75 physicians at 17 hospitals across the...
BioSig to Present at Heart Rhythm 2022
19 avr. 2022 09h10 HE
|
BioSig Technologies, Inc.
Westport, CT, April 19, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering...
BioSig to Present at NobleCon18 Capital Markets Conference
07 avr. 2022 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, April 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
United States Reprocessed Medical Devices Markets, 2022-2028 - Strategic Initiatives by Players & Increasing FDA Approvals of Reprocessed Medical Devices
01 avr. 2022 07h58 HE
|
Research and Markets
Dublin, April 01, 2022 (GLOBE NEWSWIRE) -- The "US Reprocessed Medical Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type and End-User, and Geography" report has...
BioSig Technologies, Inc. Partners with Summit Blue Capital to Provide Equipment Leasing Services
29 mars 2022 10h06 HE
|
BioSig Technologies, Inc.
Westport, CT, March 29, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...